Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection
ACS Applied Materials & Interfaces · 2024-10-02 · 16 (39) · 51981-51993
DOI: 10.1021/acsami.4c09185 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2024-09-18. Written by Zhen Guo and 5 co-authors. Institution: School of Physical Science and Technology, ShanghaiTech University, 393 Huaxia Middle Rd., Pudong, Shanghai 201210, China. Major MEDLINE topics: Helicobacter pylori, Helicobacter Infections, Hydrogels, Drug Liberation. Cited 34 times so far (Crossref); 74 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (original language)
Helicobacter pylori is the primary cause of gastric adenocarcinoma, which afflicts more than half of the world's population and seriously affects human health. However, achieving efficient treatment of H. pylori infection by effective drug delivery and bioavailability after oral administration remains a challenge due to the harsh microenvironment, short drug retention time, and physiological barriers in the stomach. Moreover, H. pylori has shown resistance to many clinical antibiotics. Antimicrobial peptides (AMPs) exhibit substantial therapeutic efficacy against H. pylori, while they are not likely to induce drug resistance, suggesting their potential utility for the treatment of diseases related to H. pylori. In this paper, we report the design and synthesis of an AMP (GE33) hydrogel with pH-responsive and controlled peptide release properties, in which the minimal inhibitory concentration of the AMP against H. pylori is as low as 1 μg/mL. GE33 self-assembles into a stable peptide hydrogel under neutral pH conditions but decomposes into monomers or oligomers under acidic conditions. Upon oral administration of the hydrogel, the acidic gastric environment would facilitate rapid release of active AMP molecules from the hydrogel and immediate targeting of H. pylori in the stomach wall. Additionally, the remaining peptide is protected in the hydrogel, extending its retention time in the stomach, so that persistent drug release is achieved. The controlled and sustained release manner of the active molecule GE33, which enhances drug bioavailability, along with its excellent bactericidal efficacy opens a great potential for treating H. pylori infection.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Physical Science and Technology, ShanghaiTech University, 393 Huaxia Middle Rd., Pudong, Shanghai 201210, China.
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201210, China.
- Institute of Materiobiology, College of Sciences, Shanghai University, Shanghai 200444, China.
Funding
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Guo, Z., Hou, Y., Tian, Y., Tian, J., Hu, J., & Zhang, Y. (2024). Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection. ACS Applied Materials & Interfaces, 16(39), 51981-51993. https://doi.org/10.1021/acsami.4c09185
Vancouver
Guo Z, Hou Y, Tian Y, Tian J, Hu J, Zhang Y. Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection. ACS Applied Materials & Interfaces. 2024;16(39):51981-51993. doi:10.1021/acsami.4c09185
BibTeX
@article{Guo2024,
author = {Guo, Zhen and Hou, Yangqian and Tian, Yu and Tian, Jiakun and Hu, Jun and Zhang, Yi},
title = {Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {39},
pages = {51981--51993},
doi = {10.1021/acsami.4c09185}
}
EUVIMED